Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
biopharma-reporter
16h
Roche acquires CAR-T developer Poseida Therapeutics for $1.5 billion
The acquisition will grant Roche full ownership over a pipeline of allogeneic CAR-T therapy candidates, including two ...
biopharma-reporter
16h
Amgen announces positive Phase 2 results for its GLP-1-GIP weight loss drug
MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Landslides in Indonesia
House Democrats targeted
Super Bowl pregame lineup
NM man awarded $412M+
Cybertruck crash kills 3
Salmonella risk recall
Mass arrests at parade
Racing pioneer McGee dies
China probes top official
Israeli airstrike on Lebanon
Boise State withdraws
Ancient species coexisted?
UKR energy sector attacked
Ohtani seeks baseball cards
Asthma attack treatment
Bird flu detected in 2nd lot
Ex-Alabama AD Battle dies
Habitat protections plan
Pug wins Best in Show
Northeast hit with rain, snow
AU passes social media ban
Uber faces FTC probe
Settles harassment lawsuit
Residents sue Givaudan
Costco recalls eggs
One-month doping ban
MD prison inmate killed
Meets Trump at Mar-a-Lago
Stowaway found on flight
Namibia to cease operations
Retires after 14 seasons
Abortions fell 2% in 2022
Pope Francis to visit Turkey
Feedback